NewAmsterdam Pharma N.V. (NAMS)
NASDAQ: NAMS
· Real-Time Price · USD
25.06
-0.11 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
24.69
-1.48%
After-hours: Aug 15, 2025, 06:42 PM EDT
NewAmsterdam Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 563.86M | 748.42M | 771.74M | 422.73M | 401.33M | 414.93M | 309.37M | n/a | 383.5M | n/a | 438.52M | 383.2K | 89.48M | 712.16K | 53.09M | 548.88K | 665.74K | 989.23K |
Short-Term Investments | 175.3M | 60.06M | 62.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 44.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 141.67M | 131.81M | 124.74M | 121.43M | 119.19M | 116.38M | 117.42M |
Other Long-Term Assets | n/a | n/a | n/a | n/a | 7.46K | -19.31K | 31.8K | n/a | 93K | n/a | 146K | n/a | -131.08M | n/a | -120.71M | -47.5K | -47.5K | -47.5K |
Receivables | 19.75M | n/a | 21.3M | 5.15M | n/a | 4.13M | 1.88M | n/a | n/a | n/a | n/a | n/a | 115M | n/a | 4.86M | 1.07M | 1.07M | n/a |
Inventory | n/a | n/a | n/a | n/a | -5.04M | 0.93 | -1.71M | n/a | n/a | n/a | -1.94M | n/a | n/a | n/a | n/a | -1.07M | -1.07M | -1.07M |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.57M | 70.63K | 1.02M | 217.75K | 5.78M | 285.7K | 352.32K | n/a |
Total Current Assets | 769.85M | 817.3M | 863.41M | 437.87M | 414.98M | 420.68M | 315.13M | n/a | 389.26M | n/a | 448.13M | 453.82K | 216.95M | 929.91K | 58.87M | 834.58K | 1.02M | 1.39M |
Property-Plant & Equipment | 620K | 607K | 673K | 724K | 734.26K | 119.87K | 91.78K | n/a | 112K | n/a | 144K | n/a | 175K | n/a | 190K | 47.5K | 47.5K | 47.5K |
Goodwill & Intangibles | 470K | 502K | 534K | 593K | 505.04K | 452.22K | 154.48K | n/a | 81.63M | n/a | 83.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 45.26M | 1.11M | 1.21M | 1.32M | 1.25M | 552.78K | 278.06K | n/a | 81.83M | n/a | 83.45M | 141.67M | 903K | 124.74M | 908K | 119.19M | 116.38M | 117.42M |
Total Assets | 815.11M | 818.41M | 864.62M | 439.19M | 416.23M | 421.24M | 315.41M | n/a | 471.1M | n/a | 531.58M | 142.12M | 217.85M | 125.67M | 59.78M | 120.02M | 117.4M | 118.82M |
Account Payables | 5.89M | 6.09M | 4.74M | 7.04M | 5.28M | 8.54M | 16.92M | n/a | 22.66M | n/a | 11.85M | n/a | 12.31M | n/a | 7.04M | 1.55M | 1.55M | 1.55M |
Deferred Revenue | n/a | 3.03M | 6.01M | 4.5M | 5.65M | 7M | 8.13M | n/a | 9.69M | n/a | 13.01M | n/a | 14.06M | n/a | 3.61M | -1.55M | -1.55M | n/a |
Short-Term Debt | 225K | n/a | 246K | n/a | n/a | n/a | -4.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.07K | 916.60 | n/a |
Other Current Liabilities | 26.61M | 25.49M | 91.03M | 29.48M | 20.46M | 33.06M | 11.4M | n/a | 9.24M | n/a | 5.55M | 3.89M | -528.12K | 97.28K | 519.69K | 8.32M | 98.2K | -1.35M |
Total Current Liabilities | 36.51M | 40.91M | 106.92M | 41.26M | 42.22M | 51.51M | 45.34M | n/a | 38.34M | n/a | 35.46M | 3.89M | 25.9M | 97.28K | 9.88M | 212.33K | 99.12K | 207.04K |
Long-Term Debt | 103K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | 18.81M | 12.44M | 16.49M | 6.98M | n/a | 7.56M | n/a | 6.75M | 8.58M | n/a | 5.36M | -14.68K | 6.93M | 8.53M | 7.76M |
Total Long-Term Liabilities | 103K | 137K | 202K | 19.07M | 12.99M | 14.6M | 8M | n/a | 10.5M | n/a | 11.6M | 8.58M | 7.53M | 5.36M | 111K | 6.93M | 8.53M | 7.76M |
Total Liabilities | 36.62M | 41.05M | 107.12M | 60.33M | 55.21M | 66.11M | 53.34M | n/a | 48.83M | n/a | 47.06M | 12.46M | 33.43M | 5.45M | 9.99M | 7.14M | 8.63M | 7.97M |
Total Debt | 328K | 389K | 448K | 506K | 523.67K | 37.08K | 54.52K | n/a | 87K | n/a | 118K | n/a | 151K | n/a | 164K | 2.07K | 916.60 | 41K |
Common Stock | 14.01M | 13.97M | 13.44M | 11.44M | 10.39M | 9.58M | 9.24M | n/a | 608.75M | n/a | 599.19M | 141.57M | 163.56M | 124.71M | 83.88M | 119.17M | 104.55M | 106.59M |
Retained Earnings | -615.46M | -598.1M | n/a | -466.39M | -419.07M | -354.21M | -288.03M | n/a | -194.46M | n/a | -119.36M | -11.91M | 19.84M | -4.5M | -34.68M | -6.3M | 1.32M | 2.43M |
Comprehensive Income | 4.33M | 4.43M | 4.47M | 4.42M | 4.12M | 3.81M | 4.02M | n/a | 7.97M | n/a | 4.69M | n/a | 1.03M | n/a | 591K | -3.75K | -3.75K | -3.75K |
Shareholders Equity | 778.5M | 777.36M | 757.5M | 378.86M | 361.02M | 355.13M | 262.06M | n/a | 422.26M | n/a | 484.52M | 129.66M | 184.42M | 120.22M | 49.79M | 112.88M | 108.76M | 110.85M |
Total Investments | 219.47M | 60.06M | 62.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 141.67M | 131.81M | 124.74M | 121.43M | 119.19M | 116.38M | 117.42M |